What is NovoCure's retained earnings?

NovoCure (NVCR) reported retained earnings of -$1.36B in Q1 2026.

How has NovoCure's retained earnings changed year-over-year?

NovoCure's retained earnings decreased by 14.6% year-over-year, from -$1.19B to -$1.36B.

What is the long-term trend for NovoCure's retained earnings?

Over 5 years (2020 to 2025), NovoCure's retained earnings has grown at a 15.4% compound annual growth rate (CAGR), from -$631.08M to -$1.29B.

What does retained earnings mean?

Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.

NovoCure NVCR Retained Earnings

Retained Earnings at other companies

Boston ScientificBSX

$6.91B+107%

MedtronicMDT

$32.64B+3.7%

Iovance Biotherapeutics, Inc.IOVA

-$2.85B-14.2%

Nuvation BioNUVB

-$1.11B-15.1%

Vir Biotechnology, Inc.VIR

-$1.32B-50.3%

Syndax PharmaceuticalsSNDX

-$1.55B-18.6%

Other financials

Income statement

See full

Revenue$174.1M+12.3%

Gross profit$135.1M+16.0%

Operating income-$67.4M-78.1%

Net income-$71.1M-107%

EPS (diluted)-$0.62-100%

Balance sheet

See full

Cash & equivalents$87.5M-31.2%

Total debt$39.5M-2.1%

Total equity$330.7M-8.6%

Total assets$787.9M-36.9%

Cash flow

See full

Operating cash flow-$13.5M+62.1%

CapEx$5.2M-51.4%

Free cash flow-$18.7M+59.7%

Valuation

See full

Market cap$1.7B-36.7%

Enterprise value$1.66B-36.3%

P/S2.5×-1.8×

Profitability

See full

Gross margin75.2%-2.0pp

Operating margin-27.2%+0.4pp

Net margin-25.7%-0.7pp

FCF margin-7.1%-2.0pp

Returns & leverage

See full

Return on equity-50%+5.4pp

Debt / equity0.1×0.0×

Current ratio2.9×+1.4×

Where this comes from

Reported directly by NovoCure in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NovoCure's retained earnings?: NovoCure (NVCR) reported retained earnings of -$1.36B in Q1 2026.
How has NovoCure's retained earnings changed year-over-year?: NovoCure's retained earnings decreased by 14.6% year-over-year, from -$1.19B to -$1.36B.
What is the long-term trend for NovoCure's retained earnings?: Over 5 years (2020 to 2025), NovoCure's retained earnings has grown at a 15.4% compound annual growth rate (CAGR), from -$631.08M to -$1.29B.
What does retained earnings mean?: Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.